North America Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The North America Muscle Relaxant Drugs Market would witness market growth of 3.6% CAGR during the forecast period (2023-2029).

The elderly population is highly susceptible to muscle pain; consequently, the aging population is the primary market driver. Additionally, the increase in surgical procedures has bolstered the market. The rising incidence of chronic back problems and the increase in the number of back surgeries are major factors propelling the growth of the market. In addition, the increasing prevalence of musculoskeletal disorders and growing consumer awareness of their management and treatment are anticipated to be the driving forces behind the expansion of the market.

Muscle relaxant medications treat muscle tension, spasm, and hyperreflexia. On the market, there are two categories of muscle relaxants which are centrally acting muscle relaxants and directly acting muscle relaxants. Neuromuscular blocking compounds are also known as direct-acting muscle relaxants. These have no activity in the central nervous system and interfere with neuronal transmission at the neuromuscular junction end plate.

One of the most prevalent chronic illnesses in Canada is back pain. Back pain affects four out of five people at some point. However, it often strikes people between the ages of 30 and 50. Men and women have back issues on an equal basis. However, the reason for back pain is not always apparent; in 85% to 90% of people with back pain, no particular cause can be found. As a result, many people with neck or back discomfort will resort to muscle relaxants for relief or as a form of treatment, helping the market in North America to grow.

The US market dominated the North America Muscle Relaxant Drugs Market by Country in 2022 thereby, achieving a market value of $1,288.8 Million by 2029. The Canada market is exhibiting CAGR of 5.6% during (2023 - 2029). Additionally, The Mexico market would experience a CAGR of 5.3% during (2023 - 2029).

Based on Drug Type, the market is segmented into Skeletal, Neuromuscular Blocking Agents and Facial Muscle Relaxant Drugs. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

Skeletal
Neuromuscular Blocking Agents
Facial Muscle Relaxant Drugs

By Route of Administration

Oral
Injectable

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacies

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Amneal Pharmaceuticals, Inc.
Ipsen Pharma Biotech SAS
Merz Pharma GmbH & Co. KGaA
Mallinckrodt PLC
Teva Pharmaceuticals Industries Ltd.
Eisai Co., Ltd.
Endo International PLC
Vertical Pharmaceuticals, LLC
SteriMax Inc.
Metacel Pharmaceuticals, LLC

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Muscle Relaxant Drugs Market, by Drug Type
- 1.4.2 North America Muscle Relaxant Drugs Market, by Route of Administration
- 1.4.3 North America Muscle Relaxant Drugs Market, by Distribution Channel
- 1.4.4 North America Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. North America Muscle Relaxant Drugs Market by Drug Type

3.1 North America Skeletal Market by Country
3.2 North America Neuromuscular Blocking Agents Market by Country
3.3 North America Facial Muscle Relaxant Drugs Market by Country

Chapter 4. North America Muscle Relaxant Drugs Market by Route of Administration

4.1 North America Oral Market by Country
4.2 North America Injectable Market by Country

Chapter 5. North America Muscle Relaxant Drugs Market by Distribution Channel

5.1 North America Hospital Pharmacy Market by Country
5.2 North America Retail Pharmacy Market by Country
5.3 North America Online Pharmacies Market by Country

Chapter 6. North America Muscle Relaxant Drugs Market by Country

6.1 US Muscle Relaxant Drugs Market
- 6.1.1 US Muscle Relaxant Drugs Market by Drug Type
- 6.1.2 US Muscle Relaxant Drugs Market by Route of Administration
- 6.1.3 US Muscle Relaxant Drugs Market by Distribution Channel
6.2 Canada Muscle Relaxant Drugs Market
- 6.2.1 Canada Muscle Relaxant Drugs Market by Drug Type
- 6.2.2 Canada Muscle Relaxant Drugs Market by Route of Administration
- 6.2.3 Canada Muscle Relaxant Drugs Market by Distribution Channel
6.3 Mexico Muscle Relaxant Drugs Market
- 6.3.1 Mexico Muscle Relaxant Drugs Market by Drug Type
- 6.3.2 Mexico Muscle Relaxant Drugs Market by Route of Administration
- 6.3.3 Mexico Muscle Relaxant Drugs Market by Distribution Channel
6.4 Rest of North America Muscle Relaxant Drugs Market
- 6.4.1 Rest of North America Muscle Relaxant Drugs Market by Drug Type
- 6.4.2 Rest of North America Muscle Relaxant Drugs Market by Route of Administration
- 6.4.3 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles

7.1 Amneal Pharmaceuticals, Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
- 7.3.1 Company Overview
7.4 Mallinckrodt PLC
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Endo International PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental Analysis
- 7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
- 7.8.1 Company Overview
7.9 SteriMax Inc.
- 7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 North America Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 2 North America Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 3 North America Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 North America Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 North America Skeletal Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Skeletal Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 North America Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 North America Injectable Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Injectable Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Retail Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 27 US Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 28 US Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 29 US Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 US Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 31 US Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 US Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 US Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Canada Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 36 Canada Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 37 Canada Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 Canada Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 39 Canada Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Canada Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Canada Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 Mexico Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 44 Mexico Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 45 Mexico Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 Mexico Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 47 Mexico Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 Mexico Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 Mexico Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Rest of North America Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 53 Rest of North America Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 Rest of North America Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 Rest of North America Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Rest of North America Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Key Information - Amneal Pharmaceuticals, INc.
TABLE 60 Key Information - Ipsen Pharma Biotech SAS
TABLE 61 Key information - Merz Pharma GmbH & Co. KGaA
TABLE 62 Key information - Mallinckrodt PLC
TABLE 63 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 64 Key Information - Eisai Co., Ltd.
TABLE 65 Key Information - Endo International PLC
TABLE 66 Key Information - Vertical Pharmaceuticals, LLC
TABLE 67 Key Information - SteriMax Inc.
TABLE 68 Key Information - Metacel Pharmaceuticals, LLC.

List of Figures

FIG 1 Methodology for the research
FIG 2 North America Muscle Relaxant Drugs Market Share by Drug Type, 2022
FIG 3 North America Muscle Relaxant Drugs Market Share by Drug Type, 2029
FIG 4 North America Muscle Relaxant Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 North America Muscle Relaxant Drugs Market Share by Route of Administration, 2022
FIG 6 North America Muscle Relaxant Drugs Market Share by Route of Administration, 2029
FIG 7 North America Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 8 North America Muscle Relaxant Drugs Market Share by Distribution Channel, 2022
FIG 9 North America Muscle Relaxant Drugs Market Share by Distribution Channel, 2029
FIG 10 North America Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 North America Muscle Relaxant Drugs Market Share by Country, 2022
FIG 12 North America Muscle Relaxant Drugs Market Share by Country, 2029
FIG 13 North America Muscle Relaxant Drugs Market by Country, 2019 - 2029, USD Million

North America Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Description

Table of Contents